click below
click below
Normal Size Small Size show me how
Chapter 1
| Term | Definition |
|---|---|
| Drug | Chemicals that act on living systems at the molecular level. |
| Pharmacology | The study of drugs and their effects on living organisms. |
| Pharmacodynamics | The study of the action of drugs on living organisms. |
| Pharmacokinetics | The study of what the body does to the drug, the measurment of the absorption, distribution, metabolism, and excretion of the drug from the body. |
| Brand (trade) name | The manufacturer's name, written with the first letter capitalized. |
| Generic name | Name for the chemical makeup of a drug, writtten in lowercase, first letter NOT capitalized. |
| Contraindications | Medical or physical conditions that make the drug inadvisable. |
| Synergism | Getting more than the desired effects when taking two drugs. |
| Tolerance | Decreased effect of a drug over time with the patient needing larger doses to achieve the same effect. |
| Toxicology | The study of the harmful effects of drugs on living tissue. |
| Theraputic effect | Desired effect of a drug. |
| Efficacy | The maximum intensity of effect or response that can be produced by a drug. |
| Chemically equivalent | When two formulations of a drug meet the chemical and physical standards. |
| Biologically equivalent | When two formulations of a drug produce similar concentrations of the drug in the blood and tissues |
| Therapeutically equivalent | When two formulations of a drug prove to have equal theraputic side effects. |
| Orphan drugs | Drugs developed to specifiically treat rare medical conditions. |
| qd | Once a day(quaque die) |
| bid | Twice a day(bis in die) |
| tid | Three times a day(ter in die) |
| qid | Four times a day(quarter in die) |
| pc | After meals(post cebum) |
| ac | Before meals(ante cebum) |
| po | By mouth(per os) |
| prn | As needed(pro re nata) |
| hs | At bedtime(hora somni) |
| Therapeutic classification is... | What is affected by the drug. |
| Pharmacological classification is... | A broader classification based on the general therapeutic effects. |
| The mechanism of action of the drug is... | A specific thing the drug does on the molecular level. |
| Schedule 1 drugs have a... | Highest abuse potential |
| Schedule 2 drugs have a... | High abuse potential |
| Schedule 3 drugs have a... | Moderate abuse potential |
| Schedule 4 drugs have a... | less abuse potential |
| Schedule 5 drugs have the... | least abuse potential |
| Schedule 2-4 drugs require... | A prescription |
| Schedule 2 drugs must be... | Written in ink or typed. |
| Schedule 2 drugs cannot be... | Telephoned in to the pharmacist -or- refilled |
| Schedule 3 & 4 drugs can be both... | Telephoned into the pharmacist -and- Refilled (No more than 5x in 6 months) |
| Preclinical testing is... | to determine if a drug is worth testing. (animal testing) Usually lasts 3 years. |
| Phase 1 testing is... | Small and then increasing doses given to a limited number of healthy human volenteers. |
| The goal of phase 1 testing is... | To determine biological effects, metabolism, safe dose range in humans, and toxic effects of the drug. |
| Phase 2 testing is... | Larger groups of humans are given the drug. |
| The goal of phase 2 testing is... | To test drug effectiveness. |
| Phase 3 testing is... | A large number of patients who have the condition for which the drug is indicated. |
| The goal of phase 3 testing is... | Safety, efficiacy, and to determine proper dosage. |
| Phase 4 testing is... | Post marketing surveillence. |
| The goal of phase 4 testing is... | To monitor the toxicity of the drug after it is released. |